Beam Therapeutics, Inc. (BEAM)

26.52 +1.00 (+3.92%) USD  |  NASDAQ  |  Mar 06, 16:00
26.27 -0.25 (-0.94%) After-Hours: 20:00
More

Beam Therapeutics Cash and Short Term Investments (Annual) : 1.245B for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Intellia Therapeutics, Inc. 449.88M
Twist Bioscience Corp. 232.43M
Pacific Biosciences of California, Inc. 279.53M
Ionis Pharmaceuticals, Inc. 2.677B
Stryker Corp. 4.10B